Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2180508, 7 pages
https://doi.org/10.1155/2017/2180508
Review Article

Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies

Department of Internal Medicine IV–Nephrology and Hypertension, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria

Correspondence should be addressed to Michael Rudnicki; ta.ca.dem-i@ikcindur.leahcim

Received 3 March 2017; Accepted 20 April 2017; Published 9 May 2017

Academic Editor: Björn Meijers

Copyright © 2017 Michael Rudnicki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Michael Rudnicki, “Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies,” BioMed Research International, vol. 2017, Article ID 2180508, 7 pages, 2017. https://doi.org/10.1155/2017/2180508.